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An efficient, solvent-free and one-pot procedure for the synthesis of pyrido[2,3-d]pyrimidine derivatives by condensation 
of aromatic aldehydes, malononitrile and 6-amino-1,3-dimethyl uracil at 90°C catalyzed by lactic acid as an inexpensive, 
biological and eco-friendly compound is described. The remarkable benefits of this procedure are green and environmentally 
friendly reaction conditions, high yields, short reaction time, simple methodology and easy workup. 
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Multicomponent reactions (MCRs) have growing 
importance for several reasons including atom 
economy, reduced steps of work up, time saving, 
simple reaction design and minimized waste 
generation1. The first MCR was reported by Strecker 
for the synthesis of amino acids2. Pyrido[2,3-
d]pyrimidines with uracil core have received
considerable attention because of their biological and
pharmacological activities for example, antitumor3,
antihypertension4, antibacterial5, antifungal6 and
antimicrobial properties7. Uracil derivatives are the
building blocks for the synthesis of N-containing species
of biological and pharmacological significance8.
All compounds of pyrazolopyrimidines9, xanthine
derivatives10. Pyrazolopyridines11 and pyramid-
dopyrimidines12 have been synthesized by the
functionalization of uracil derivatives (Figure 1).
Several synthetic methodologies have been reported
for the preparation of them such as TEBAC13, nano-
MgO14, microwave irradiation15, electrolysis16,
L-proline17 and ionic liquid18. However, many of these
methods have limitations such as low yields, long
time and specific conditions.
In continuation of our researches on MCRs19-26, 
herein, we describe the efficient and simple synthesis 
of highly functionalized pyrido[2,3 d]pyrimidines by 
three component reactions of 6-aminouracil with 
malononitrile and aldehydes at 90°C to synthesize 
pyrido[2,3 d]pyrimidines in good yields (Scheme I). 
Results and Discussion 
At first, we optimized the reaction conditions in 
the preparation of pyrido[2,3-d]pyrimidines by 
performing the condensation of malononitrile, 4-
chlorobenzaldehyde and 6-amino-1,3-dimethyluracil 
utilizing the lactic acid under various conditions 
(Table I). The best results were obtained at 90°C 
under solvent-free conditions (Table I, entries 12). 
After optimization of the reaction conditions, we 
employed several aromatic aldehydes containing 
electron-withdrawing or electron-releasing groups for 
the synthesis of the other derivatives under optimized 
condition. Table II show that all products were 
obtained successfully in short reaction time and good  
Figure 1 — Some examples of biologically relevant compounds
having pyrido[2,3-d]pyrimidine skeleton 





yields. It was shown that the aldehydes with electron-
withdrawing groups gave shorter times and  
good yields than aldehydes with electron-releasing 
groups. 
 
To demonstrate the merit of our work, we 
compared the results of this work with the literature as 
shown in Table III. The data in Table III show that 
lactic acid can act as an efficient catalyst with respect 
 
 
Scheme I — Synthesis of pyrido[2,3-d]pyrimidine derivatives 
 
Table I — Effect of the solvent, temperature and amount of the catalyst in the synthesis of compound 4f 
Entry Solvent Temperature (°C) Catalyst (mol %) Time (min) Isolated Yield (%)a 
1 H2O 70 10 60 58 
2 EtOH 70 10 60 63 
3 CHCl3 70 10 70 54 
4 THF 70 10 70 48 
5 − 70 10 45 68 
6 − RT 10 120 Trace 
7 − 50 10 65 60 
8 − 80 10 35 88 
9 − 90 10 25 91 
10 − 100 10 20 89 
11 − 90 5 30 90 
12 − 90 15 20 94 
13 − 90 20 20 92 
 
Table II — Synthesis of pyrido[2,3-d]pyrimidines utilizing the lactic acid in solvent-free conditions 
Entry Product Time (min) Isolated Yield (%)a m.p. (°C) Found m.p. (°C) Reported [Ref] 
1 4a, Ar = Ph 30 90 >300 >30018 
2 4b, Ar = 4-MeC6H4 40 88 >300 >300
13 
3 4c, Ar = 4-MeOC6H4 35 89 >300 >300
13 
4 4d, Ar = 2-ClC6H4 25 93 >300 >300
14 
5 4e, Ar = 3-ClC6H4 30 91 >300 >300
14 
6 4f, Ar = 4-ClC6H4 20 94 >300 >300
14 
7 4g, Ar = 3-BrC6H4 30 92 >300 >300
18 
8 4h, Ar = 4-BrC6H4 20 93 >300 >300
13 
9 4i, Ar = 4-FC6H4 20 94 >300 >300
18 
12 4j, Ar = 3-FC6H4 30 92 >300 This work 
13 4k, Ar = 2-MeC6H4 30 91 >300 This work 
14 4l, Ar = 3-Pyridyl 25 92 290-292 This work 
15 4m, Ar = 4-Pyridyl 25 93 >300 This work 
16 4n, Ar = 2-Thienyl 30 91 >300 This work 
 
Table III — Comparison of lactic acid with previously reported catalysts for the synthesis of compound 4f 
Entry Catalyst Time (min) Conditions Yield (%) Ref. 
1 TEBAC 720 H2O, 90°C 96 13 
2 Electrolysis 20 EtOH, KBr 71 16 
3 Nano-MgO 15 H2O, 80°C 90 14 
5 Lactic acid 20 Solvent free, 90°C 94 Present work 
 




to reaction yields and the obtained products. The 
products 4l-p are new compounds which were 
characterized by IR, 1H and 13C NMR and MS. 
 
Experimental Section 
All the chemicals were purchased from chemical 
producers Merck or Fluka and used without further 
purification. Melting points and IR spectra of all 
compounds were determined using an FT-IR-JASCO-
460 plus spectrometer and Electrothermal 9100 
apparatus and are uncorrected. The 1H and 13C NMR 
spectra of compounds were recorded on a Bruker 
DRX-300 Avance instrument in DMSO-d6 at 300 
MHz. Vincinal aromatic hydrogen coupling constants 
were in the range of 6-8 Hz. Mass spectra were 
obtained on the Sciex-3200 Technology spectrometer 
operating at an ionization potential of 70 eV. 
 
General procedure for the synthesis of 2-
aminopyrimidinomethylnaphthols 
To a mixture of aromatic aldehyde (1.0 mmol), 
malononitrile (1.0 mmol) and 6-amino-1,3-
dimethyluracil (1.0 mmol), lactic acid (15 mol %) 
were added. The mixture was stirred at 90°C and 
reaction progress was monitored through TLC. After 
completion of the reaction, the mixture was cooled 
and washed with water. Lactic acid was removed 
from the mixture. The filter cake obtained was 




IR (KBr): 3452, 3317, 3223, 2212, 1716, 1667, 
1624, 1557, 1508, 1439, 1369, 1309 cm−1; 1H NMR 
(300 MHz, DMSO-d6): δ 3.09 (s, CH3, 3H), 3.52 (s, 





IR (KBr): 3457, 3310, 3219, 2212, 1716, 1667, 
1624, 1563, 1509, 1440, 1367 cm−1; 1H NMR (300 
MHz, DMSO-d6): δ 2.39 (s, CH3, 3H), 3.09 (s, CH3, 
3H), 3.51 (s, CH3, 3H), 7.11 (d, Haromatic, 2H,), 7.23 (d, 





IR (KBr): 3458, 3316, 3218, 2213, 1714, 1664, 
1622, 1550, 1506, 1435, 1367, 1291 cm−1; 1H NMR 
(300 MHz, DMSO-d6): δ 3.09 (s, CH3, 3H), 3.51  
(s, CH3, 3H), 3.83 (s, CH3, 3H), 6.97 (d, Haromatic, 2H), 





IR (KBr): 3455, 3367, 3273, 2254, 1689, 1667, 1645, 





IR (KBr): 3397, 3328, 3224, 2224, 1712, 1662, 





IR (KBr): 3461, 3320, 3220, 2214, 1715, 1662, 
1622, 1568, 1548, 1509, 1494, 1369, 1301 cm−1; 
1H NMR (300 MHz, DMSO-d6): δ 3.09 (s, CH3, 3H), 
3.51 (s, CH3, 3H), 7.26 (d, Haromatic, 2H), 7.49 (d, 





IR (KBr): 3460, 3317, 3222, 2215, 1717, 1660, 




IR (KBr): 3460, 3313, 3220, 2960, 2214, 1715, 
1663, 1623, 1569, 1546, 1509, 1493, 1438, 1369, 
1277 cm−1; 1H NMR (300 MHz, DMSO-d6): δ 3.09  
(s, CH3, 3H), 3.51 (s, CH3, 3H), 7.21 (d, Haromatic, 2H), 





IR (KBr): 3401, 3329, 3224, 2228, 1715, 1671, 
1634, 1598, 1557, 1510, 1440, 1368, 1311 cm−1; 
1H NMR (300 MHz, DMSO-d6): δ 3.10 (s, CH3, 3H), 






IR (KBr): 3487, 3400, 3324, 3222, 3075, 2219, 
1715, 1670, 1631, 1563, 1492, 1430, 1391,  
1367 cm−1; 1H NMR (300 MHz, DMSO-d6): δ 3.10 (s, 




CH3, 3H), 3.52 (s, CH3, 3H), 7.08-7.31 (m, Haromatic, 
3H), 7.46-7.53 (m, Haromatic, 1H), 7.95 (s, NH2, 2H); 
13C NMR (75 MHz, DMSO-d6): δ 28.1, 30.0, 88.8, 
99.1, 114.8, 115.1, 115.3, 115.5, 123.9, 130.3, 130.5, 
139.8, 140.0, 151.3, 154.0, 158.1, 158.8, 160.4, 160.6, 
163.7; MS: m/z (%) 185.1 (4), 256.2 (6), 274.2 (15), 
282.2 (20), 290.2 (12), 302.2 (25), 304.2 (100), 326.1 




IR (KBr): 3455, 3311, 3217, 2953, 2213, 1715, 
1655, 1622, 1564, 1546, 1494, 1435, 1370, 1278 
cm−1; 1H NMR (300 MHz, DMSO-d6): δ 2.02 (s, CH3, 
3H), 3.09 (s, CH3, 3H), 3.53 (s, CH3, 3H), 7.01 (d, 
Haromatic, 1H), 7.21-7.34 (m, Haromatic, 3H), 7.90 (s, 
NH2, 2H); 
13C NMR (75 MHz, DMSO-d6): δ 19.5, 
28.1, 30.0, 88.6, 99.3, 115.4, 125.9, 127.0, 128.4, 
129.8, 134.3, 137.7, 151.3, 154.1, 158.8, 159.6, 160.9; 
MS: m/z (%) 59.0 (4), 62.0 (100), 88.9 (3), 97.0 (7), 





IR (KBr): 3350, 3198, 2214, 1709, 1642, 1575, 
1480, 1444, 1418, 1370 cm−1; 1H NMR (300 MHz, 
DMSO-d6): δ 3.10 (s, CH3, 3H), 3.52 (s, CH3, 3H), 
7.47 (t, Haromatic, 1H), 7.72-7.76 (m, Haromatic, 1H), 7.99 
(s, NH2, 2H), 8.46 (d, Haromatic, 1H), 8.63 (dd, Haromatic, 
1H); 13C NMR (75 MHz, DMSO-d6): δ 28.2, 30.1, 






IR (KBr): 3382, 3040, 2220, 1708, 1666, 1602, 
1571, 1539, 1519, 1440, 1367 cm−1; 1H NMR (300 
MHz, DMSO-d6): δ 3.10 (s, 3H, CH3), 3.52 (s, 3H, 
CH3), 7.29 7.31 (dd, Haromatic, 2H), 8.03 (s, NH2, 2H), 
8.66-8.68 (dd, Haromatic, 2H); 
13C NMR (75 MHz, 
DMSO-d6): δ 28.1, 30.0, 88.0, 98.7, 115.3, 122.6, 
145.9, 149.6, 151.3, 154.0, 156.8, 158.9, 160.7; MS: 






IR (KBr): 3446, 3315, 3222, 2957, 2212, 1715, 
1667, 1623, 1557, 1510, 1450, 1427, 1367, 1277 
cm−1; 1H NMR (300 MHz, DMSO-d6): δ 3.12 (s, CH3, 
3H), 3.50 (s, CH3, 3H), 7.07-7.15 (m, Haromatic, 2H), 
7.72-7.74 (dd, Haromatic, 1H), 7.91 (s, NH2, 2H); 
13C NMR (75 MHz, DMSO-d6): δ 28.2, 30.1, 90.1, 
100.0, 115.5, 127.1, 127.9, 128.1, 136.7, 151.2, 152.6, 
154.1, 158.5, 160.5; MS: m/z (%) 102.2 (12), 230.3 




In summary, we have demonstrated a highly 
efficient one-pot procedure for the three-component 
synthesis of pyrido[2,3-d]pyrimidines via condensation 
of an aldehyde, malononitrile and 6-amino-1,3-
dimethyluracil in the presence of the lactic acid as an 
environmentally benign catalyst in solvent-free 
conditions. Lactic acid is green, inexpensive and 
readily commercially available catalyst. Easy and 
clean preparation, operationally simple, good yields, 
reasonable time, product purity, non-toxic and mild 
conditions are advantages of this method. 
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